Delivery Order SPE2DB22D1041-SPE2DB24FTYR3
- Not listed
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the delivery of NORVASC 2.5 mg tablets. The contract has a firm-fixed price of $1,792.72 and an ultimate completion date of August 28, 2024. It was awarded as a delivery order, with no set-aside designation. Amerisourcebergen Drug Corp's Corporate Office Division holds this contract, which is likely part of a larger Indefinite Delivery Contract...
- This federal contract award is a delivery order issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $2,296.53, is for the delivery of NORVASC 2.5 MG TABLET 90S, a cardiovascular medication. The contract is a firm fixed-price Indefinite Delivery Contract (IDC) that runs through December 2022. This award is not designated as a set-aside contract. AmerisourceBergen holds a larger...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of the global pharmaceutical sourcing and distribution company Amerisourcebergen Corporation. The $2,244.76 firm fixed price delivery order is for the supply of NORVASC 10 mg tablets. Amerisourcebergen Drug Corp holds an Indefinite Delivery Contract (IDC) with DLA, valued up to $999,999,999.00 through December 2025, which serves as the primary vehicle for the company to...
- This federal contract award to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, was issued by the Defense Logistics Agency (DLA) Troop Support Medical. The $1,167.46 firm fixed price delivery order is for the supply of NORVASC 5 MG TABLET 90S, a pharmaceutical product, in support of military treatment programs and facilities. The award is associated with a larger indefinite delivery contract (IDC) between Amerisourcebergen Drug Corp and DLA, valued at up to...
- This federal contract award is a delivery order (SPE2DB23FV5E7) issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The $13,396.63 firm fixed-price contract is for the delivery of NORVASC 2.5 MG TABLET 90S, a cardiovascular medication. The award has an ultimate completion date of February 15, 2023. Amerisourcebergen holds a larger $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a...
- The U.S. Defense Logistics Agency Troop Support Medical awarded a firm fixed price delivery order contract to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, a leading global pharmaceutical distribution company. The $10,726.53 contract is for the supply of NORVASC 2.5 MG TABLET 90S. This delivery order is part of a larger indefinite delivery contract (IDC) awarded solely to Amerisourcebergen Drug Corp, valued at up to $999,999,999.00, which serves as the primary...
- This is a delivery order contract awarded by the Defense Logistics Agency (DLA), a defense agency, to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of NORVASC 5 MG TABLET 90S, a prescription medication, with a ceiling value of $1,392.17 and a performance period through June 30, 2025. The contract is a firm fixed-price delivery order, with no set-aside designation, indicating open competition....
- This federal contract award, valued at $33,253.74, was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp Corporate Office Division. The contract is for the delivery of Norvasc 2.5 mg tablets, a prescription medication. This is a firm fixed-price delivery order contract with a completion date of January 6, 2023. Amerisourcebergen, a major pharmaceutical distributor in the United States, has been awarded numerous federal contracts to supply a wide...
- This federal contract award, worth $4,652.90, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The award is a delivery order contract for the supply of Norvasc 5 mg tablets, a cardiovascular medication, with a completion date of July 8, 2024. The contract is part of a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 that Amerisourcebergen holds with the DLA Troop Support Medical....
- This is a federal contract award from the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The contract, valued at $83,150.57, is for the delivery of 90-count bottles of Norvasc 10 mg tablets, a medication used to treat high blood pressure and chest pain. The contract has a completion date of February 10, 2023 and is a Firm Fixed Price Delivery Order. The contract was not set aside for any specific business type. Amerisourcebergen Drug Corp is a...
- SPE2DB22D1041Indefinite Delivery Contract
- SPE2DB22D1041-SPE2DB24FTYR3Delivery Order
This federal contract award, with ID SPE2DB22D1041|SPE2DB24FTYR3, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The $2,121.11 firm-fixed-price delivery order is for the supply of NORVASC 5 MG TABLET 90S, a cardiovascular medication. The contract has an ultimate completion date of December 5, 2023 and was awarded on December 4, 2022. Amerisourcebergen Drug Corp holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as the primary vehicle for the company to provide a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. The company also maintains a separate $750,000 IDC with the Department of Justice Federal Bureau of Investigation for similar medical commodities. These IDCs enable efficient government procurement of essential pharmaceutical and medical supplies for military personnel, veterans, and other federal beneficiaries.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $2.1k | 12/4/23 |